Director / PDMR Shareholding and Issue of Equity

Summary by AI BETAClose X

Kazera Global plc announced that Chief Executive Officer Paul Dulieu purchased 2,130,000 ordinary shares at £0.014 each, increasing his beneficial interest to approximately 0.18% of the issued share capital. Additionally, Executive Director Richard Jennings converted £40,868 of loan interest into 4,086,800 new ordinary shares at £0.01 per share, preserving cash and increasing his holding to approximately 24.98% of the issued share capital. The 4,086,800 conversion shares are expected to be admitted to trading on AIM on November 4, 2026, bringing the total issued share capital to 1,170,104,706 ordinary shares.

Disclaimer*

Kazera Global PLC
30 October 2026
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain. 

 

30 October 2026

Kazera Global plc

("Kazera" or the "Company")

 

Director / PDMR Shareholding and Issue of Equity following Interest Conversion

 

Kazera Global plc (AIM: KZG), the AIM-quoted investment company, announces the following director dealings and the allotment of new ordinary shares in settlement of loan interest.

 

Director share purchase

The Company has been notified that Paul Dulieu, Chief Executive Officer, has purchased 2,130,000 ordinary shares of 0.1p each in the Company ("Ordinary Shares") at a price of £0.014 per share on 29 October 2026.

 

Following the purchase, Paul Dulieu's beneficial interest in the Company is 2,130,000 Ordinary Shares, representing approximately 0.18% of the Company's current issued share capital.

 

Conversion of loan interest into equity

Further to the Company's announcement of 30 April 2026 regarding the extension and increase of its unsecured loan facility with Richard Jennings, Executive Director, Mr Jennings has elected, pursuant to the terms of his amended loan agreement with the Company, to convert £40,868 of interest owed to him into 4,086,800 new Ordinary Shares at a conversion price of £0.01 per share (the "Conversion Shares").

 

The Board has approved the allotment of the Conversion Shares, with settlement scheduled for 1 December 2026. The Conversion Shares will be issued in satisfaction of the £40,868 interest liability, preserving an equivalent amount of cash within the Company. The conversion relates solely to interest and does not reduce the outstanding principal under the loan agreement. No cash will be paid by the Company in respect of the interest converted.

 

Following the allotment of the Conversion Shares, together with his connected persons, Mr Jennings' interest in the Ordinary shares of the Company will increase to 292,324,570 Ordinary Shares (such interest including a long spreadbet over 38,000,000 Ordinary Shares), representing approximately 24.98% of the Company's issued share capital.

 

Admission and total voting rights

Application will be made for the 4,086,800 Conversion Shares to be admitted to trading on AIM ("Admission"). The Conversion Shares will rank pari passu in all respects with the Company's existing Ordinary Shares.

 

It is expected that Admission will become effective and dealings in the Conversion Shares will commence at 8.00 a.m. on or around 4 November 2026.

 

Following Admission of the Conversion Shares, the total number of Ordinary Shares in the capital of the Company in issue will be 1,170,104,706 each with voting rights.

 

This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's share capital pursuant to the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

The notifications below, made in accordance with the requirements of the UK Market Abuse Regulation, provide further details.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Paul Dulieu

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Kazera Global plc

b)

Legal Entity Identifier

213800U4PZ148SFLGY26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 0.1 pence each

 

 

GB00B830HW33

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Currency

GBP

 

d)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.014

2,130,000


e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

2,130,000 Ordinary Shares, bought at a price of £0.014 per share, totalling £29,820.

f)

Date of the transaction

29 October 2026

g)

Place of the transaction

London Stock Exchange, AIM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Richard Stephen Jennings

2

Reason for the notification

a)

Position/status

Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Kazera Global plc

b)

Legal Entity Identifier

213800U4PZ148SFLGY26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 0.1 pence each

 

 

GB00B830HW33

b)

Nature of the transaction

Acquisition upon conversion of loan interest

c)

Currency

GBP

 

d)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.01

4,086,800


e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

Aggregated volume: 4,086,800 Ordinary Shares; price: 1 penny per share; aggregate consideration: £40,868 

f)

Date of the transaction

29 October 2026

g)

Place of the transaction

Outside a trading venue

 

ENDS

 

For further information, visit www.kazeraglobal.com or contact:

 

Kazera Global plc

Paul Dulieu, Chief Executive Officer

info@kazeraglobal.com  

Strand Hanson Limited (Nominated, Financial Adviser and Joint Broker)

Christopher Raggett / Ritchie Balmer / Imogen Ellis

Tel: +44 (0)207 409 3494

Zeus Capital Limited (Joint Broker)

Harry Ansell / Simon Johnson / Katy Mitchell 

Tel: +44 (0)203 829 5000

 

Notes

Kazera Global plc (LON: KZG) is a diversified commodity investment company focused on unlocking value through production growth and disciplined portfolio management. While production builds at its Whale Head Minerals (Heavy Mineral Sands) and Deep Blue Minerals (diamond) assets in South Africa's Northern Cape province, the Company also continues to assess new opportunities to expand its growth pipeline and deliver sustainable returns.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100